Document is current
Any future updates will be listed below
-
Authors
Oh, Sun-Young
Kang, Jin-Ju
Park, Hong-Kyun
Cho, Soo-Jin
Hong, Yooha
Kang, Mi-Kyoung
Moon, Heui-Soo
Lee, Mi Ji
Song, Tae-Jin
Suh, Young Ju
Chu, Min Kyung
-
Funding
Funding for this research was provided by:
National Research Foundation of Korea (2022R1A2B5B01001933)
- License Information
-
More Information
Article History
Received: 21 March 2024
Accepted: 5 July 2024
First Online: 11 July 2024
Competing interests
: MKC was a site investigator for a multicenter trial sponsored by Biohaven Pharmaceuticals, Allergan Korea, and Ildong Pharmaceutical Company. He received lecture honoraria from Eli Lilly and Company, Handok-Teva, and Ildong Pharmaceutical Company over the past 24 months. He received Grants from Yonsei University College of Medicine (6-2021-0229), the Korea Health Industry Development Institute (KHIDI) (HV22C0106), and a National Research Foundation of Korea (NRF) Grant from the Korean government (MSIT) (2022R1A2C1091767). The other authors declare no conflicts of interest.
